For many years, Tau has been a key target for therapeutic intervention for the development of disease-modifying therapies. With the emerging of new targeted protein degradation by proteolysis targeting chimeras (PROTACs), Tau-targeting PROTAC has emerged as a promising strategy for the drug discovery of related diseases. Creative Biolabs is a leading product manufacturer and service provider in the PROTAC space. With an unrelenting drive in ligand research and the PROTAC industry, Creative Biolabs is executing our strategies to bring comprehensive Tau-binding ligand design services to our clients. Tau PROTAC ligand https://www.creative-biolabs.c....om/protac/ligand-des